申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0303961A2
公开(公告)日:1989-02-22
The present invention provides novel compounds such as certain aryloxy indanamines which are useful as anti-depressants and as inhibitors of synaptic norepinephrine and serotonin uptake. The present invention also provides an improvement in the treatment of depression which comprises inhibiting synaptic serotonin and epinepherine uptake.
本发明提供了新型化合物,如某些芳氧基茚满胺,它们可用作抗抑郁剂和突触去甲肾上腺素和血清素摄取抑制剂。本发明还提供了一种治疗抑郁症的改进方法,其中包括抑制突触5-羟色胺和表啡肽的摄取。